Search Within

Jedd D Wolchok

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (63)
  2. Meeting Abstract (44)
  3. Book Section (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (109)
  2. GSK Faculty (109)
  3. Melanoma and Immunotherapeutics Service (109)
  4. Population Sciences Research Program (109)
  5. Solid Tumor Oncology Division (109)
  6. Epidemiology and Biostatistics (99)

More Groups

People
  1. Katherine Panageas (92)
  2. Paul Chapman (59)
  3. Michael Postow (48)
  4. Margaret Callahan (36)
  5. Alexander Shoushtari (29)
  6. Jianda Yuan (22)

More People

Years
  1. 2024 (1)
  2. 2023 (4)
  3. 2022 (4)
  4. 2021 (7)
  5. 2020 (9)
  6. 2019 (7)

More Years

Publications
  1. Journal of Clinical Oncology (36)
  2. Journal for ImmunoTherapy of Cancer (10)
  3. Clinical Cancer Research (7)
  4. Journal of Investigative Dermatology (5)
  5. Cancer Research (4)
  6. Melanoma Research (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (36)
  2. American Association for Cancer Research (15)
  3. Biomed Central Ltd (10)
  4. Elsevier Science, Inc. (5)
  5. Lippincott Williams & Wilkins (5)
  6. Wiley Blackwell (5)

More Publishers

Results (109)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety of infusing ipilimumab (ipi) over 30 minutes (min)
    Meeting Abstract

    Momtaz, P.; Park, V.; Panageas, K.; Guillen, J. D.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Patterns of long-term survival following Ipilimumab (Ipi): The Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience
    Meeting Abstract

    Page, D. B.; Naidoo, J.; Momtaz, P.; Bogatch, K.; Kuk, D.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Postow, M.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • The Memorial Sloan Kettering Cancer Center (MSKCC) experience of systemic therapy in mucosal melanoma
    Meeting Abstract

    Bitas, C.; Shoushtari, A. N.; Bluth, M. J.; Bhuchar, G.; Hester, R. H.; Romero, J.; Fitzpatrick, L.; Lefkowitz, R. A.; Panageas, K.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Safety and clinical activity of combining systemic ipilimumab with isolated limb infusion in patients with in-transit melanoma
    Meeting Abstract

    Ariyan, C. E.; Lefkowitz, R. A.; Panageas, K.; Callahan, M. K.; Misholy, O.; Bello, D.; Fisher, C.; Kotin, A.; Siegelbaum, R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab
    Journal Article

    Yuan, J. D.; Zhou, J.; Dong, Z.; Tandon, S.; Kuk, D.; Panageas, K. S.; Wong, P.; Wu, X. Q.; Naidoo, J.; Page, D. B.; more...
    Cancer Immunology Research (2014)

    Fulltext@MSK | Save
  • Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes
    Journal Article

    Kitano, S.; Postow, M. A.; Ziegler, C. G. K.; Kuk, D.; Panageas, K. S.; Cortez, C.; Rasalan, T.; Adamow, M.; Yuan, J. D.; Wong, P.; more...
    Cancer Immunology Research (2014)

    Fulltext@MSK | Save
  • Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: A randomized clinical trial
    Journal Article

    Carvajal, R. D.; Sosman, J. A.; Quevedo, J. F.; Milhem, M. M.; Joshua, A. M.; Kudchadkar, R. R.; Linette, G. P.; Gajewski, T. F.; Lutzky, J.; Lawson, D. H.; more...
    JAMA - Journal of the American Medical Association (2014)

    Fulltext@MSK | Save
  • Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab
    Meeting Abstract

    Yuan, J.; Zhou, J.; Dong, Z.; Tandon, S.; Kuk, D.; Panageas, K. S.; Wong, P.; Wolchok, J. D.; Hodi, F. S.
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Prognostic implication of KIT mutations in melanoma
    Meeting Abstract

    Roth, K. G.; Zabor, E. C.; Colgan, M. N.; Wolchok, J. D.; Chapman, P. B.; Schwartz, G. K.; Panageas, K. S.; Carvajal, R. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Pharmacodynamic effect of ipilimumab on absolute lymphocyte count (ALC) and association with overall survival in patients with advanced melanoma
    Meeting Abstract

    Postow, M. A.; Chasalow, S. D.; Yuan, J.; Kuk, D.; Panageas, K. S.; Cheng, M.; Shahabi, V.; Berman, D. M.; Wolchok, J. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save